Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-VEGF Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04597632
What this trial is testing

An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 248
Not applicableUnknownNCT04976244
What this trial is testing

Brolucizumab for CNV Associated With Pathologic Myopia

Who this might be right for
Pathologic Myopia
The Filatov Institute of Eye Diseases and Tissue Therapy 50
Not applicableEnrolling By InvitationNCT07503613
What this trial is testing

Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy

Who this might be right for
Vestibular Schwannoma
Akouos, Inc. 100
Not applicableStudy completedNCT03963596
What this trial is testing

Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Myopia

Who this might be right for
Pathologic Myopia
The Filatov Institute of Eye Diseases and Tissue Therapy 122
Not applicableStudy completedNCT07375901
What this trial is testing

The Blood-Aqeous Barrier During Anti-Angiogenic Therapy in Exudative Age-Related Macular Degeneration

Who this might be right for
AMD
The Filatov Institute of Eye Diseases and Tissue Therapy 30
Testing effectiveness (Phase 2)Study completedNCT00492284
What this trial is testing

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
QLT Inc. 162
Not applicableNot Yet RecruitingNCT07310836
What this trial is testing

A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Hepatocellular Carcinoma Beyond UCSF Criteria Before Liver Transplantation

Who this might be right for
Hepatocellular CarcinomaLiver Transplantation
Ningbo Medical Center Lihuili Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00557492
What this trial is testing

Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer

Who this might be right for
Pancreatic Cancer
Amer Zureikat 59
Early research (Phase 1)Study completedNCT01120288
What this trial is testing

A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases

Who this might be right for
NeoplasmsLiver Metastases
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Study completedNCT04626128
What this trial is testing

Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Clearside Biomedical, Inc. 27
Testing effectiveness (Phase 2)Study completedNCT04444167
What this trial is testing

Anti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Akeso 59
Testing effectiveness (Phase 2)Study completedNCT04311606
What this trial is testing

Anti-VEGF Therapy for Acute Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Massachusetts Eye and Ear Infirmary 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT06449209
What this trial is testing

Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy

Who this might be right for
Extensive-stage Small-cell Lung CancerSmall-cell Lung Cancer
BioNTech SE 110
Testing effectiveness (Phase 2)Study completedNCT00511706
What this trial is testing

Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationAge-Related Maculopathy
Allergan 243
Large-scale testing (Phase 3)Study completedNCT04592419
What this trial is testing

Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Kodiak Sciences Inc 568
Not applicableActive Not RecruitingNCT06846073
What this trial is testing

Early Combined Use of Dexamethasone Intravitreal Implant and Anti-VEGF in the Treatment of DME.

Who this might be right for
Diabetic Macular Edema (DME)
Second Affiliated Hospital, Zhejiang University, School of Medicine 70
Large-scale testing (Phase 3)WithdrawnNCT03784443
What this trial is testing

Combined Ranibizumab and Iluvien for Diabetic Macular Oedema

Who this might be right for
Diabetic Macular EdemaDiabetes
Imperial College London
Not applicableStudy completedNCT01447043
What this trial is testing

Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA)

Who this might be right for
Ophthalmology, Macular Degeneration
Bayer 2,609
Large-scale testing (Phase 3)Study completedNCT06270836
What this trial is testing

Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)

Who this might be right for
Diabetic Retinopathy
Kodiak Sciences Inc 255
Not applicableWithdrawnNCT02812030
What this trial is testing

Aflibercept for Retinopathy in the Real World

Who this might be right for
Diabetic Retinopathy
Timothy Jones
Next Page